(Circulation. 2006;113:995-1004.)
© 2006 American Heart Association, Inc.
Molecular Cardiology |
From the Departments of Pharmacology & Cell Biophysics (W.Z., Q.Y., J.Q., J.R.W., A.P., G.C., B.M., X.S., J.J., J.C.B., H.-S.W., J.E.J.S., E.G.K.), Internal Medicine (H.S.H., Y.M., F.S., G.W.D.), and Medicine (S.B.L.), University of Cincinnati College of Medicine, Cincinnati, Ohio; Department of Pediatrics (J.C.B., J.D.M.), University of Cincinnati, Children Hospital Medical Center, Cincinnati, Ohio; Cardiovascular Research (P.P.), Orion Pharma, Espoo, Finland; and Department of Physical Sciences (A.A.), University of Helsinki, Helsinki, Finland.
Correspondence to Evangelia G. Kranias, PhD, Academy of Athens, Foundation of Biomedical Research, Department of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, Cincinnati, OH 45267-0575. E-mail Litsa.Kranias{at}uc.edu
Received August 16, 2005; revision received December 6, 2005; accepted December 14, 2005.
Background Phospholamban (PLN) is an inhibitor of the Ca2+ affinity of sarcoplasmic reticulum (SR) Ca2+-ATPase (SERCA2). The amino acid sequence of PLN is highly conserved, and although all species contain asparagine (Asn), human PLN is unique in containing lysine (Lys) at amino acid 27.
Methods and Results Human PLN was introduced in the null background. Expression of human PLN, at similar levels to mouse wild-type PLN, resulted in significant decreases in the affinity of SERCA2 for Ca2+, attributed to unique spatial conformation of this PLN form and increases in its monomeric active unit compared with mouse PLN. The increased inhibition by human PLN was associated with attenuated cardiac contractility in the intact-animal, organ, and cardiomyocyte levels and with depressed calcium kinetics. These inhibitory effects could not be fully reversed even on maximal isoproterenol stimulation. There were no alterations in the expression levels of SERCA2, calsequestrin, ryanodine receptor, and FKBP12, although the sodium/calcium exchanger and the L-type Ca2+ channel expression levels were upregulated. The depressed function resulted in increased heart/body weight ratios and phosphorylation levels of Akt, p38, and Erk1/2.
Conclusions Human PLN may play a more inhibitory role than that of other species in Ca2+ cycling. Expression of human PLN in the mouse is compensated by alterations in Ca2+-handling proteins and cardiac remodeling in an effort to normalize cardiac contractility. Thus, the unique amino acid sequence of human PLN may be critical in maintaining a high cardiac reserve, which is of paramount importance in the regulation of human cardiac function.
This article has been cited by other articles:
![]() |
Q. Yuan, G.-C. Fan, M. Dong, B. Altschafl, A. Diwan, X. Ren, H. H. Hahn, W. Zhao, J. R. Waggoner, L. R. Jones, et al. Sarcoplasmic Reticulum Calcium Overloading in Junctin Deficiency Enhances Cardiac Contractility but Increases Ventricular Automaticity Circulation, January 23, 2007; 115(3): 300 - 309. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |